Cargando…
A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes
Multiple complex intracellular cascades contributing to Hunter syndrome (mucopolysaccharidosis type II) pathogenesis have been recognized and documented in the past years. However, the hierarchy of early cellular abnormalities leading to irreversible neuronal damage is far from being completely unde...
Autores principales: | Badenetti, Lorenzo, Manzoli, Rosa, Trevisan, Marta, D’Avanzo, Francesca, Tomanin, Rosella, Moro, Enrico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290981/ https://www.ncbi.nlm.nih.gov/pubmed/37357221 http://dx.doi.org/10.1038/s41598-023-37138-5 |
Ejemplares similares
-
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment
por: Mazzoccoli, Gianluigi, et al.
Publicado: (2013) -
Changes in Glycogen and Glycosaminoglycan Levels in Hepatocytes of Iduronate-2-Sulfatase Knockout Mice before and after Recombinant Iduronate-2-Sulfatase Supplementation
por: Lee, Jee Hyun, et al.
Publicado: (2011) -
Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene
por: Holmes, Roger S.
Publicado: (2017) -
Bioinformatic Analysis of the Human Recombinant Iduronate 2-Sulfate Sulfatase
por: Morales-Álvarez, Edwin D., et al.
Publicado: (2016) -
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
por: Demydchuk, Mykhaylo, et al.
Publicado: (2017)